Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/10/1992 | WO1992021760A1 Mutant proteolytic enzymes from bacillus |
12/10/1992 | WO1992021758A1 Mycobacterium proteins and applications |
12/10/1992 | WO1992021757A1 Nematode-responsive plant promoters |
12/10/1992 | WO1992021756A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/10/1992 | WO1992021754A1 Dna which codes for secretin receptor and polypeptide which is coded for by said dna |
12/10/1992 | WO1992021753A1 Insecticidal proteins and method for plant protection |
12/10/1992 | WO1992021752A1 Human lactoferrin |
12/10/1992 | WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
12/10/1992 | WO1992021750A1 Eukaryotic expression vectors with regulation of rna processing |
12/10/1992 | WO1992021747A1 Methods and compositions of genetic stress response systems |
12/10/1992 | WO1992021699A1 Biocidal proteins |
12/10/1992 | WO1992021693A1 Three highly informative microsatellite repeat polymorphic dna markers |
12/10/1992 | WO1992021374A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments |
12/10/1992 | WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
12/10/1992 | WO1992021240A1 Suppressor t-cell hybridoma |
12/10/1992 | WO1992021229A1 Ζx174 transgenic mammals |
12/10/1992 | WO1992017493A3 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv) |
12/10/1992 | WO1992014821A3 Nestin expression as an indicator of neuroepithelial tumors |
12/10/1992 | WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
12/10/1992 | WO1992013078A3 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
12/10/1992 | WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
12/10/1992 | WO1992009690A3 Enrichment method for variant proteins with altered binding properties |
12/10/1992 | DE4118155A1 Acid-stable mutants of human rhinovirus serotype 14 - used for treatment of rhino-viral infection obtd. by incubating wild type virus at varying pH cycles |
12/10/1992 | CA2110924A1 Method and materials for introducing dna into prevotella ruminicola |
12/10/1992 | CA2110687A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments |
12/10/1992 | CA2110404A1 Human lactoferrin |
12/10/1992 | CA2110403A1 Biocidal proteins |
12/10/1992 | CA2110389A1 Mycobacterium proteins and applications |
12/10/1992 | CA2110169A1 Nematode-responsive plant promoters |
12/10/1992 | CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
12/10/1992 | CA2109819A1 Insecticidal proteins and method for plant protection |
12/10/1992 | CA2109579A1 Eukaryotic expression vectors with regulation of rna processing |
12/10/1992 | CA2103365A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/10/1992 | CA2103046A1 Suppressor t-cell hybridoma |
12/09/1992 | EP0517515A2 Method of purifying DNA |
12/09/1992 | EP0517418A2 A method for cloning of a gene for Pol I type DNA polymerase |
12/09/1992 | EP0517367A1 Novel nematode-active toxins and genes which code therefor |
12/09/1992 | EP0517292A1 Recombinant Avipox virus |
12/09/1992 | EP0517174A2 LFA-3 protein and derivatives |
12/09/1992 | EP0517111A1 A novel type II restriction endonuclease, PmeI, obtainable from pseudomonas mendocina and a process for producing the same |
12/09/1992 | EP0517024A2 Tetravalent bispecific receptors, their preparation and use |
12/09/1992 | EP0516958A2 Caffeoyl-coA-3-O-methyltransferase gene |
12/09/1992 | EP0516859A1 Non-a non-b hepatitis virus antigen protein |
12/09/1992 | EP0516787A1 Expression systems |
12/09/1992 | EP0516721A1 Antigenic proteins of plasmodium |
12/09/1992 | EP0516664A1 Transgenic animals, cells and cell lines therefrom, and their use |
12/09/1992 | EP0516655A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine. |
12/09/1992 | EP0516647A1 Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for these polypeptides, and their preparation and use |
12/09/1992 | EP0463144A4 Magnetically responsive fluorescent polymer particles and application thereof |
12/08/1992 | US5169941 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto |
12/08/1992 | US5169940 Nucleotide sequences of protein MTP40 of M. tuberculosis |
12/08/1992 | US5169939 Chimeric antibodies |
12/08/1992 | US5169933 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
12/08/1992 | US5169930 Integrin with preferential binding to fibronectin not vitronectin |
12/08/1992 | US5169835 Pregancy specific proteins applications |
12/08/1992 | US5169784 Baculovirus dual promoter expression vector |
12/08/1992 | US5169772 Rupturing cell envelope in osmotically stabilized medium; two-step washing with buffered solutions of differing ph; chromatographic separation |
12/08/1992 | US5169770 Rapid simplified gene transfer in bean plants using bacterial vector |
12/08/1992 | US5169768 Method of biosynthesis of phenylalanine |
12/08/1992 | US5169766 Amplification of nucleic acid molecules |
12/08/1992 | US5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras |
12/08/1992 | US5169763 Contains promoter for expressing non-cleavable dna fragments with signal peptide in mammalian cells |
12/08/1992 | US5169761 Dna encoding and expression systems for alveolar surfactant proteins |
12/08/1992 | US5169760 Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters |
12/08/1992 | US5169755 Process for inducing cytochrome P-450 enzymes in streptomyces bacteria and determining the mutagenicity of chemicals |
12/08/1992 | US5169629 Process of controlling lepidopteran pests, using bacillus thuringiensis isolate denoted b.t ps81gg |
12/08/1992 | US5169628 Vaccines |
12/08/1992 | CA1311203C Dipeptidase, its isolation from lactic acid bacteria, antibodies against the dipeptidase, the use of the dipeptidase and of the antibodies against it |
12/08/1992 | CA1311202C Method for producing mucoid and phage resistant group n streptococcus strains from non-mucoid and phage sensitive parent strains |
12/08/1992 | CA1311201C Desazapurine-nucleoside derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof fornucleic acid sequencing and as antiviral agents |
12/08/1992 | CA1311192C Tumor specific assay for ca125 ovarian cancer antigen |
12/07/1992 | WO1992021759A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
12/07/1992 | WO1992021375A1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
12/07/1992 | CA2088666A1 Nucleotide and peptide sequences of hepatitis c virus isolate, diagnostic and therapeutic applications |
12/06/1992 | WO1992021690A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
12/06/1992 | CA2088787A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
12/04/1992 | WO1992021979A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/04/1992 | CA2103142A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/04/1992 | CA2070233A1 Tetravalent bispecific receptors, the preparation and use thereof |
12/03/1992 | DE4217616A1 Verbessertes verfahren zur herstellung von glycosyltransferasen Improved process for the production of glycosyltransferases |
12/02/1992 | EP0516540A1 Oligonucleotides useful as reactants for the in vitro detection of HIV retrovirus infections and HIV retrovirus detection method |
12/02/1992 | EP0516443A1 Vectors and methods for assaying the regulation of apolipoprotein ai synthesis |
12/02/1992 | EP0516396A1 Eimeria acervulina dna probes |
12/02/1992 | EP0516395A2 Eimeria necatrix dna probes |
12/02/1992 | EP0516391A2 Eimeria brunetti dna probes |
12/02/1992 | EP0516386A1 Eimeria mitis DNA probes |
12/02/1992 | EP0516385A1 Eimeria tenella DNA probes |
12/02/1992 | EP0516384A1 Eimeria praecox DNA probes |
12/02/1992 | EP0516383A2 Eimeria maxima dna probes |
12/02/1992 | EP0516381A2 Species-specific method for identifying infecticity of eimeria species |
12/02/1992 | EP0516306A2 Novel bacillus thuringiensis isolates active against hymenopteran pests and gene(s) encoding hymenopteran-active toxins |
12/02/1992 | EP0516287A2 Human rotavirus of serotype 3 HCR3A, reassortants thereof and vaccine compositions containing them |
12/02/1992 | EP0516286A1 Hepatitis B virus surface proteins with reduced host carbohydrate content |
12/02/1992 | EP0516270A2 Non-A, non-B hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides |
12/02/1992 | EP0516245A1 DNA Sequencing |
12/02/1992 | EP0516200A1 Detergent compositions containing stabilized enzymes |
12/02/1992 | EP0516190A2 Monoclonal antibodies, process for preparing them and their use |
12/02/1992 | EP0516135A2 Human immunodeficiency virus-related immune preparation |
12/02/1992 | EP0515698A1 PROCESS FOR PRODUCING D-$g(a)-AMINO ACID |
12/02/1992 | EP0515660A1 Hla dqbeta dna typing. |